Table of Contents

August 20, 2002; 137 (4)

Articles

  • Economic Analysis of Influenza Vaccination and Antiviral Treatment for Healthy Working Adults

    • Patrick Y. Lee,
    • David B. Matchar,
    • Dennis A. Clements,
    • Joel Huber,
    • John D. Hamilton,
    • and Eric D. Peterson
    Ann Intern Med August 20, 2002 137:225-231

    Vaccination is cost-beneficial in most influenza seasons in healthy working adults. Although the benefits of antiviral therapy for persons with influenza infection appear to justify its cost, head-to-head trials of the various antiviral therapies are needed to determine the optimal treatment strategy.

  • Is Duplex Ultrasonography Useful for the Diagnosis of Giant-Cell Arteritis?

    • Carlo Salvarani,
    • Mauro Silingardi,
    • Angelo Ghirarduzzi,
    • Giovanni Lo Scocco,
    • PierLuigi Macchioni,
    • GianLuigi Bajocchi,
    • Marco Vinceti,
    • Fabrizio Cantini,
    • Ido Iori,
    • and Luigi Boiardi
    Ann Intern Med August 20, 2002 137:232-238

    Evidence on ultrasonography of any halo or a halo 1 mm or greater in thickness around temporal arteries only modestly increased the probability of biopsy-proven giant-cell arteritis but did not improve the diagnostic accuracy of a careful physical examination.

  • Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy

    • Ole Kirk,
    • Peter Reiss,
    • Caterina Uberti-Foppa,
    • Markus Bickel,
    • Jan Gerstoft,
    • Christian Pradier,
    • Ferdinand W. Wit,
    • Bruno Ledergerber,
    • Jens D. Lundgren,
    • Hansjakob Furrer,
    • and for Seven European HIV Cohorts*
    Ann Intern Med August 20, 2002 137:239-250

    Maintenance therapy against previous infection with cytomegalovirus, Mycobacterium avium complex, Toxoplasma gondii, or Cryptococcus neoformans in patients with HIV infection can be interrupted after sustained CD4 count increases to greater than 200 (or possibly 100 to 200) × 106 cells/L for at least 6 months after the start of potent antiretroviral therapy.

Brief Communications

  • Oral Vitamin K Lowers the International Normalized Ratio More Rapidly Than Subcutaneous Vitamin K in the Treatment of Warfarin-Associated Coagulopathy: A Randomized, Controlled Trial

    • Mark A. Crowther,
    • James D. Douketis,
    • Terri Schnurr,
    • Luigi Steidl,
    • Valentina Mera,
    • Carolina Ultori,
    • Achille Venco,
    • and Walter Ageno
    Ann Intern Med August 20, 2002 137:251-254

    Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in asymptomatic patients who had supratherapeutic international normalized ratio values while receiving warfarin.

Academia and Clinic

  • U.S. Centers for Disease Control and Prevention Guidelines for the Treatment of Sexually Transmitted Diseases: An Opportunity To Unify Clinical and Public Health Practice

    • Kimberly A. Workowski,
    • William C. Levine,
    • and Judith N. Wasserheit
    Ann Intern Med August 20, 2002 137:255-262

    Effective clinical management of sexually transmitted diseases is a strategic common element in efforts to prevent HIV infection and to improve reproductive and sexual health. This paper presents new recommendations from the 2002 CDC Guidelines for the Treatment of Sexually Transmitted Diseases in the context of current disease trends and public health.

  • Tests of Glycemia for the Diagnosis of Type 2 Diabetes Mellitus

    • R Graham Barr,
    • David M. Nathan,
    • James B. Meigs,
    • and Daniel E. Singer
    Ann Intern Med August 20, 2002 137:263-272

    This paper discusses tests of glycemia for the diagnosis of type 2 diabetes mellitus, with particular reference to the 1997 diagnostic criteria of the American Diabetes Association.

Review

  • Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease

    • Linda L. Humphrey,
    • Benjamin K.S. Chan,
    • and Harold C. Sox
    Ann Intern Med August 20, 2002 137:273-284

    This meta-analysis discusses postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease.

Editorials

  • Discontinuing Prophylaxis against Recurrent Opportunistic Infections in HIV-Infected Persons: A Victory in the Era of HAART

    • Jonathan E. Kaplan,
    • Henry Masur,
    • and King K. Holmes
    Ann Intern Med August 20, 2002 137:285-287

    In this issue, Kirk and colleagues provide important data on discontinuation of secondary prophylaxis after episodes of cytomegalovirus disease, Mycobacterium avium complex disease, toxoplasmosis encephalitis, and extrapulmonary cryptococcosis. However, questions remain about which patients can most safely discontinue secondary prophylaxis.

  • Articles on Diagnostic Tests: A New Series and an Invitation to Authors

    • Alan M. Garber,
    • Cynthia Mulrow,
    • and Harold C. Sox
    Ann Intern Med August 20, 2002 137:288-289

    Advances in diagnostic testing have been among the most significant medical innovations of recent years, but they have not simplified the choice of diagnostic strategies. The need for an evidence-based approach to such choices has never been greater. With the article by Barr and colleagues, this issue inaugurates a series on the selection and interpretation of diagnostic tests.

  • Postmenopausal Hormone Replacement Therapy: How Could We Have Been So Wrong?

    • Christine Laine
    Ann Intern Med August 20, 2002 137:290

    The early stoppage and release of the main results of the estrogen plus progestin component of the Women's Health Initiative have caused millions of postmenopausal women to confront their medicine cabinets in confusion. In this issue, Humphrey and colleagues summarize data that pointed toward a sizable reduction in the risk for coronary events in women who took hormone replacement therapy after menopause.

On Being a Doctor

  • Precious Cargo

    • Kathie Kadri
    Ann Intern Med August 20, 2002 137:291-292

    It was 11 December 1979, just past dawn. He was across the room from me, in an incubator because of a difficult birth. The most beautiful newborn I had ever seen.

On Being a Patient

  • Drop-in

    • John L. McClenahan
    Ann Intern Med August 20, 2002 137:293-294

    “Doctor B. just walked in,” my receptionist said. “He wants to see you.” So, I said to myself, he finally made it. Five missed appointments in 3 months. I finished my coffee, got up, and faced him across a crowded waiting room.

Letters

  • Delirium at the End of Life

    • Thomas E. Finucane
    Ann Intern Med August 20, 2002 137:295

  • Delirium at the End of Life

    • David Casarett and
    • Sharon Inouye
    Ann Intern Med August 20, 2002 137:295

  • Clinical Trials Testing the Homocysteine Hypothesis

    • Cynthia M. Carlsson and
    • James H. Stein
    Ann Intern Med August 20, 2002 137:295-296

  • Infliximab Therapy for Complicated Sarcoidosis

    • Matthew C. Cook
    Ann Intern Med August 20, 2002 137:296

  • Infliximab Therapy for Complicated Sarcoidosis

    • Terence M. O'Connor,
    • Fergus Shanahan,
    • and Charles P. Bredin
    Ann Intern Med August 20, 2002 137:296-297

  • Infliximab Therapy for Complicated Sarcoidosis

    • Arthur M.F. Yee and
    • Mark B. Pochapin
    Ann Intern Med August 20, 2002 137:297

  • Colitis Associated with Variant Clostridium difficile

    • Quentin B. Deming and
    • Edward S. Hyman
    Ann Intern Med August 20, 2002 137:297-298

  • Colitis Associated with Variant Clostridium difficile

    • Stuart Johnson,
    • Dale N. Gerding,
    • and Lance R. Peterson
    Ann Intern Med August 20, 2002 137:298

  • Effect of Angiotensin-Converting Enzyme Inhibitors on Progression of Nondiabetic Renal Disease

    • Tazeen H. Jafar,
    • Christopher H. Schmid,
    • and Andrew S. Levey
    Ann Intern Med August 20, 2002 137:298-299

  • Ischemic Colitis Associated with Anti-β2 Glycoprotein-I Antibody

    • Nelson S. Yee,
    • Stephen J. Schuster,
    • and Gary R. Lichtenstein
    Ann Intern Med August 20, 2002 137:299

  • Correction: Angiotensin-Converting Enzyme Inhibitors and Progression of Nondiabetic Renal Disease

    Ann Intern Med August 20, 2002 137:299

Medical Writings: Book Notes

  • Inflammatory Mechanisms in Allergic Diseases

    • John J. Condemi
    Ann Intern Med August 20, 2002 137:300

  • Male Sexual Function: A Guide to Clinical Management

    • David F. Penson
    Ann Intern Med August 20, 2002 137:300

Current Clinical Issues

  • Chronic HIV Infection: Can Anyone Afford a Drug Holiday?

    • Brigid Kane
    Ann Intern Med August 20, 2002 137:301-304

Book Listings

Medical Notices

Summaries for Patients

  • Influenza Vaccination or Antiviral Treatment for Healthy Working Adults: An Economic Analysis

    Ann Intern Med August 20, 2002 137:I-22

  • Physical Examination or Duplex Ultrasonography for the Diagnosis of Giant-Cell Arteritis

    Ann Intern Med August 20, 2002 137:I-26

  • Can Maintenance Therapy for Opportunistic Infections in HIV-Infected People Be Stopped Safely?

    Ann Intern Med August 20, 2002 137:I-34

  • Vitamin K Reverses Overanticoagulation with Warfarin More Quickly When Given by Mouth Than by Injection

    Ann Intern Med August 20, 2002 137:I-39

  • Postmenopausal Hormone Replacement Therapy To Prevent Chronic Conditions: Recommendations from the U.S. Preventive Services Task Force

    Ann Intern Med August 20, 2002 137:I-48
« Previous | Next Issue »

This Issue

August 20, 2002; 137 (4)
  1. Articles
  2. Brief Communications
  3. Academia and Clinic
  4. Review
  5. Editorials
  6. On Being a Doctor
  7. On Being a Patient
  8. Letters
  9. Medical Writings: Book Notes
  10. Current Clinical Issues
  11. Book Listings
  12. Medical Notices
  13. Summaries for Patients

Search in this issue:

Current Issue

  1. November 3, 2009, 151 (9)
  1. Alert me to current issues